These results reveal the novel interplay between the LTβ/LTβR inflammatory pathway and key oncogenes that drive liver malignancy, particularly lipogenic hepatic foci and ICC-like lesions. Here, LTBR is linked to intrahepatic cholangiocarcinoma.